antivirals

First trial of Ebola antiviral begins in DRC outbreak

Researchers in the Democratic Republic of Congo began enrolling participants on July 14 in the EBO-PEP trial, the first clinical study testing Gilead Sciences' experimental antiviral obeldesivir as post-exposure prophylaxis against the Bundibugyo Ebola virus, according to ALIMA, one of…